UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Pharmaceutical Digital Design: From Chemical Structure through Crystal Polymorph to Conceptual Crystallization Process

Burcham, Christopher L; Doherty, Michael F; Peters, Baron G; Price, Sarah L; Salvalaglio, Matteo; Reutzel-Edens, Susan M; Price, Louise S; ... Zhao, Yongsheng; + view all (2024) Pharmaceutical Digital Design: From Chemical Structure through Crystal Polymorph to Conceptual Crystallization Process. Crystal Growth and Design , 24 (13) pp. 5417-5438. 10.1021/acs.cgd.3c01390. Green open access

[thumbnail of burcham-et-al-2024-pharmaceutical-digital-design-from-chemical-structure-through-crystal-polymorph-to-conceptual-2.pdf]
Preview
Text
burcham-et-al-2024-pharmaceutical-digital-design-from-chemical-structure-through-crystal-polymorph-to-conceptual-2.pdf - Other

Download (5MB) | Preview

Abstract

A workflow for the digital design of crystallization processes starting from the chemical structure of the active pharmaceutical ingredient (API) is a multistep, multidisciplinary process. A simple version would be to first predict the API crystal structure and, from it, the corresponding properties of solubility, morphology, and growth rates, assuming that the nucleation would be controlled by seeding, and then use these parameters to design the crystallization process. This is usually an oversimplification as most APIs are polymorphic, and the most stable crystal of the API alone may not have the required properties for development into a drug product. This perspective, from the experience of a Lilly Digital Design project, considers the fundamental theoretical basis of crystal structure prediction (CSP), free energy, solubility, morphology, and growth rate prediction, and the current state of nucleation simulation. This is illustrated by applying the modeling techniques to real examples, olanzapine and succinic acid. We demonstrate the promise of using ab initio computer modeling for solid form selection and process design in pharmaceutical development. We also identify open problems in the application of current computational modeling and achieving the accuracy required for immediate implementation that currently limit the applicability of the approach.

Type: Article
Title: Pharmaceutical Digital Design: From Chemical Structure through Crystal Polymorph to Conceptual Crystallization Process
Open access status: An open access version is available from UCL Discovery
DOI: 10.1021/acs.cgd.3c01390
Publisher version: http://dx.doi.org/10.1021/acs.cgd.3c01390
Language: English
Additional information: Copyright © 2024 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Chemical Engineering
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10194474
Downloads since deposit
656Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item